Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | AKR1B10 | O60218 | 4/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | PAM | P19021 | 1/20 | 0.45 |
| ▸ | NAAA | Q02083 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19846622 | 0.95 | TSHR (0.51) | THRBTSHRALDH1A1CYP3A4AKR1B10 | |
| SCHEMBL67824 | 0.95 | TSHR (0.51) | THRBTSHRALDH1A1CYP3A4AKR1B10 | |
| SCHEMBL138625 | 0.91 | THRB (0.55) | THRBTSHRALDH1A1CYP3A4AKR1B10 | |
| SCHEMBL11339150 | 0.83 | AKR1B10 (0.63) | THRBTSHRALDH1A1CYP3A4AKR1B10 | |
| SCHEMBL8217316 | 0.83 | AKR1B10 (0.63) | THRBTSHRALDH1A1CYP3A4AKR1B10 | |
| SCHEMBL8217319 | 0.83 | AKR1B10 (0.63) | THRBTSHRALDH1A1CYP3A4AKR1B10 | |
| SCHEMBL2164917 | 0.83 | AKR1B10 (0.55) | ALDH1A1AKR1B10AKR1B1PAMNAAA | |
| SCHEMBL11339149 | 0.83 | AKR1B10 (0.63) | THRBTSHRALDH1A1CYP3A4AKR1B10 | |
| SCHEMBL9457687 | 0.82 | THRB (0.45) | THRBTSHRALDH1A1CYP3A4AKR1B10 | |
| SCHEMBL891181 | 0.81 | MMP1 (0.51) | THRBALDH1A1AKR1B10AKR1B1PAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11331939-B2 | Recording media | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-05-17 | — | — | US | claimed |
| US-20200301296-A1 | EMULSION AGGREGATION PROCESS | XEROX CORPORATION | 2020-09-24 | — | — | US | claimed |
| US-20200180338-A1 | RECORDING MEDIA | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2020-06-11 | — | — | US | claimed |
| EP-3266908-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER NANOCOMPOSITE FILAMENTS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2020-05-06 | — | — | EP | claimed |
| US-10570290-B2 | Anti-bacterial aqueous ink compositions comprising metal ion composite ionomer resins | XEROX CORPORATION (US) | 2020-02-25 | — | — | US | claimed |
| US-10543707-B2 | Recording media | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2020-01-28 | — | — | US | claimed |
| EP-3266613-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER COMPOSITE POWDERS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2019-10-16 | — | — | EP | claimed |
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | XEROX CORPORATION (US) | 2019-09-10 | — | — | US | claimed |
| US-10113059-B2 | Anti-bacterial metallo ionomer polymer nanocomposite powders and methods of making the same | XEROX CORPORATION (US) | 2018-10-30 | — | — | US | claimed |
| US-10095140-B2 | Styrene/acrylate and polyester resin particles | XEROX CORPORATION (US) | 2018-10-09 | — | — | US | claimed |
| US-5965316-A | Wax processes | XEROX CORPORATION (US) | 1999-10-12 | — | — | US | claimed |
| US-5962179-A | EXCELLENT TRIBOELECTRIC CHARGING CHARACTERISTICS AND WHICH TONERS CAN POSSESS HIGH IMAGE GLOSS, AND EXCELLENT IMAGE FIX AT LOW FUSING TEMPERATURES. | XEROX CORPORATION (US) | 1999-10-05 | — | — | US | claimed |
| US-5928832-A | Toner adsorption processes | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| US-5928830-A | Latex processes | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| EP-0928994-A2 | Toner preparation processes | Xerox Corporation (US) | 1999-07-14 | — | — | EP | claimed |
| US-5869216-A | LATEX, AGGREGATION, FUSION/COALESCENCE, SURFACE TREATMENT WITH A SALICYLIC ACID OR A CATECHOL | XEROX CORPORATION (US) | 1999-02-09 | — | — | US | claimed |
| US-5863698-A | MIXING COLORANT COMPRISING PHOSPHATE-CONTAINING SURFACTANT, LATEX EMULSION, HEATING, STABILIZING | XEROX CORPORATION (US) | 1999-01-26 | — | — | US | claimed |
| US-5827633-A | Toner processes | XEROX CORPORATION (US) | 1998-10-27 | — | — | US | claimed |
| US-5766818-A | Toner processes with hydrolyzable surfactant | XEROX CORPORATION (US) | 1998-06-16 | — | — | US | claimed |
| US-5766817-A | AGGREGATING COLORANT DISPERSION WITH LATEX MINIEMULSION CONTAINING POLYMER AND IONIC AND NONIONIC SURFACTANTS, COALESCING THE AGGREGATES GENERATED | XEROX CORPORATION (US) | 1998-06-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10113059-B2 | Anti-bacterial metallo ionomer polymer nanocomposite powders and methods of making the same | RPN1, RPN2, MSH2 | THRB 3844/4885TSHR 4205/4885ALDH1A1 2365/4885 |
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | TERB1, NBAS, MFAP1 | THRB 3537/4885TSHR 4098/4885ALDH1A1 2758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.